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Abstract
Background: Several FIDELIS projects (Fund for Innovative DOTS Expansion through Local Initiatives to Stop TB) in
Tanzania were conducted by the National Tuberculosis and Leprosy Programme (NTLP) during the years 2004-2008
to strengthen diagnostic and treatment services. These projects collected information on treatment delay and some
of it was available for research purposes. With this database our objective was to assess the duration and
determinants of treatment delay among new smear positive pulmonary tuberculosis (TB) patients in FIDELIS
projects, and to compare delay according to provider visited prior to diagnosis.
Methods: Treatment delay among new smear positive TB patients was recorded for each patient at treatment
initiation and this information was available and fairly complete in 6 out of 57 districts with FIDELIS projects
enrolling patients between 2004 and 2007; other districts had discarded their forms at the time of analysis. It was
analysed as a cross sectional study.
Results: We included 1161 cases, 10% of all patients recruited in the FIDELIS projects in Tanzania. Median delay
was 12 weeks. The median duration of cough, weight loss and haemoptysis was 12, 8 and 3 weeks, respectively.
Compared to Hai district Handeni had patients with longer delays and Mbozi had patients with shorter delays.
Urban and rural patients reported similar delays. Patients aged 15-24 years and patients of 65 years or older had
longer delays. Patients reporting contact with traditional healers before diagnosis had a median delay of 15 weeks
compared to 12 weeks among those who did not. Patients with dyspnoea and with diarrhoea had longer delays.
Conclusion: In this patient sample in Tanzania half of the new smear positive pulmonary tuberculosis patients had
a treatment delay longer than 12 weeks. Delay was similar in men and women and among urban and rural
patients, but longer in the young and older age groups. Patients using traditional healers had a 25% longer
median delay.
Background
In order to better control tuberculosis (TB) and reduce
patients’ suffering a timely diagnosis and initiation of
treatment is crucial. Early treatment reduces the number
of micro-organisms released from patients to the envir-
onment, it reduces the suffering of the patients and
minimizes sequelae in the lungs and body. The potential
for finding ways of shortening the duration of the dis-
ease and hence reduced transmission gives treatment
delay a high priority among topics for study in global
TB control, whose central policy is the DOTS strategy
(Directly observed treatment - short course).
A recent systematic review showed that some charac-
teristics of patients are associated with delayed treat-
ment initiation [1]. Longer delays were found among
patients with pre-existing chronic cough, patients with
negative sputum smear, and patients living in rural areas
or with geographical barriers. Another systematic review
of delay in sub-Saharan Africa showed that travel time
and consultation with a traditional healer was associated
with delay [2]. A small study from Rwanda did not
show longer delays among HIV infected TB patients,
but studies are not consistent in this matter. The dura-
tion and the importance of the risk factors vary substan-
tially according to geography and culture [3]. In a study
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in Tanzania the median total treatment delay was esti-
mated 90 days (13 weeks) [4], and another study from
same country showed a median patient delay of 120
days (17 weeks) [5]. Initial care-seeking from traditional
healers may increase the delay [5,6].
Globally, the WHO targeted to reach 70% detection of
new TB cases by 2005 but achieved only around 55%
[7]. The Fund for Innovative DOTS Expansion through
Local Initiatives to Stop TB (FIDELIS) was created by
the Canadian International Development Agency
(CIDA) to assist the TB control system to detect “miss-
ing” cases through DOTS expansion - and the Interna-
tional Union Against Tuberculosis and Lung Disease
(The Union) was selected to manage the initiative [8]. A
one-year grant was given to 51 successful applicants in
18 countries where the guiding principle was to support
local initiatives of innovative approaches to detect addi-
tional new smear positive cases (NSP), with an emphasis
on patients with limited access to health services, while
maintaining a high cure rate. The results of the various
interventions have been analysed [9]. Every patient’s
access to health services was assessed by determining
the duration of symptoms prior to diagnosis and initia-
tion of treatment, in addition to health seeking activities
before diagnosis. This created for each project a valuable
database on treatment delay of their patients, enrolling
all the relevant patients notified in the respective dis-
tricts. This database was not designed for scientific ana-
lysis, but to monitor progress toward targets for project
management. The National TB and Leprosy Programme
(NTLP) in Tanzania received such a one-year grant in
four out of six FIDELIS application rounds of between
2004 and 2008. Our hypothesis was that patients who
visit traditional healers have longer delays. Using the
existing routinely collected information our objective
was to assess the duration and determinants of treat-
ment delay of TB patients enrolled in Tanzanian FIDE-
LIS projects, and to compare the treatment delay by
health care provider visited prior to diagnosis.
Methods
The location of the study was six districts in rural and
urban settings of various regions in Tanzania. A total of
57 districts had been involved in the FIDELIS projects
of Tanzania between 2004 and 2008, selected by the
NTLP based on the district performance and pre-project
needs assessment. There are around 130 districts in
Tanzania, with approximately 25,000 new smear positive
TB patients notified annually. In the six study districts
the person responsible for reporting had taken care of
all FIDELIS forms, including questions about treatment
delay. The forms had been routinely filled, and the
forms were collected at the end of the project; unfortu-
nately, all the other districts had discarded their forms
by the time of this analysis. In Tanzania TB is diagnosed
and treated at most public clinics and selected private
clinics, all supported and supervised by the NTLP and
reporting their TB cases.
The study had a cross sectional design using data rou-
tinely collected from new smear positive TB patients at
treatment initiation by the clinician or nurse dealing
with these patients. Every new smear positive patient
was diagnosed based on detecting acid-fast bacilli in at
least two out of three sputum smears, and was inter-
viewed with a short questionnaire about symptom dura-
tion from onset until diagnosis, and the health care
seeking activities during this time i.e. visiting public
clinics, private practitioners, or traditional healers. The
information recorded included age, sex, district, symp-
toms and their duration, and visits to care provider
prior to diagnosis. The participants were enrolled
between October 2004 and April 2007.
The drugs of all the participants were provided by the
National TB and Leprosy Programme (NTLP) through
the routine services from either public or private part-
ners reporting to the NTLP. In most instances the per-
son(s) responsible for the TB register at the facilities
conducted the short interviews required by the project
and sent to the NTLP headquarters the results together
with the case finding and treatment outcomes reports.
The questionnaires were kept at the districts and these
were later collected by NTLP, who gave permission to
use the data for research purposes. The data from the
forms were double-entered anonymously into the com-
puter by EpiData software and validated, and exported
to SPSS for further analysis. Simple frequencies and
cross tabulations were undertaken, and median and
mean delay was calculated to estimate central tendency.
We used 95% confidence intervals as estimates of preci-
sion. Non-parametric tests (Mann-Whitney) were used
to identify statistically significant differences in delay.
Multiple logistic regression was used to quantify the risk
factors for patients having a treatment delay of 12 weeks
or more, and we included in the regression model the
variables district, sex, age group, cough, haemoptysis,
fever, and weight loss. Multiple linear regression was
used to quantify the excess delay for the risk factors,
and because of markedly skewed data on delay we ana-
lysed logarithmically transformed delay adjusting by the
same variables.
Ethics approval was discussed with the director of the
National Institute of Medical Research which is the
body responsible for medical research ethics, and we
were told by email that as retrospective analysis of rou-
tine work it did not require ethical permit in Tanzania.
Ethics approval was obtained from the Ethics Advisory
Group of The Union, as this is required for any research
activity undertaken by consultants in this organization.
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Results
Between 2004 and 2007 the study enrolled 1,161 new
smear positive TB patients out of 11,375 patients regis-
tered in all FIDELIS projects in Tanzania. The partici-
pants had a mean treatment delay of 15.2 weeks (95%
CI 14.5-15.8), and the 25-, 50-, and 75-centile was 8,12
and 20 weeks, respectively, demonstrating that the fre-
quency distribution of treatment delay was skewed with
a tail to the right.
Table 1 shows the treatment delay of the participants
by district, setting, sex and age. The district of Handeni
shows a longer delay (median 14 weeks) and Mbozi a
shorter delay (median 10 weeks) compared to the other
districts (12 weeks). Males and females had similar
delay, as did most age groups, except ages 15-24 and
older than 65 with longer delay. Urban and rural dwell-
ers had similar delay.
Table 2 shows symptom duration and treatment delay
according to the symptoms experienced by the patients.
Patients who indicated dyspnoea as a symptom had a
longer median delay than those who did not, as did
patients who indicated diarrhoea. The median duration
of cough was 12 weeks, whereas for weight loss it was 8
weeks, and for haemoptysis it was 3 weeks.
Table 3 shows treatment delay according to health
services consulted before diagnosis of their current dis-
ease. Patients who had been to a traditional healer had a
median treatment delay of 15 weeks compared to 12
weeks among those who had not (p < 0.001); in urban
settings 20.8% reported such a visit and in rural areas
19.4%. The patients who had consulted a traditional
healer visited him a median of 5 weeks before diagnosis.
Patients who had consulted a private practitioner had
slightly shorter delay than those who had not.
Multiple logistic regression analysis showed that
patients who had experienced weight loss had more
than 3 times higher adjusted odds ratio (OR 3.4; 95% CI
2.3-5.1) of having treatment delay for 12 weeks or more,
and patients with haemoptysis had a 60% higher odds
ratio (OR 1.6; 95% CI 1.1-2.2). In multiple linear regres-
sion of logarithmically transformed delay we found that
patients with weight loss had 1.5 weeks longer delay
Table 1 Treatment delay among participants with new smear positive pulmonary tuberculosis in Tanzania
n Mean Delay (weeks) 95% CI for mean Median delay (weeks) Mann-Whitney test
All 1161 15.2 12
District
Handeni 75 19.2 (16.5-22.0) 14 p < 0.01
Hai 264 12.1 (11.1-13.1) 12 reference
Lushoto 12 12.6 (12.2-13.0) 12.5 p = 0.8
Mbeya 518 16.9 (15.7-18.1) 12 p < 0.01
Mbozi 243 13.7 (12.5-14.9) 10 p = 0.17
Muheza 49 15.6 (14.1-17.1) 12 p < 0.01
Setting
Urban 345 15.9 (14.5-17.2) 12 p = 1.0
Rural 816 14.9 (14.1-15-6) 12
Sex
Males 680 14.4 (13.6-15.2) 12
Females 476 16.3 (15.2-17.5) 12
Missing 5 11.6 12
Agegroup
0-4y - - -
5-14y 24 18.8 (13.9-23.6) 14.5 p = 0.04
15-24y 186 15.3 (13.7-17.0) 12 p = 0.69
25-34y 430 15.1 (13.9-16.2) 12 reference
35-44y 303 15.4 (14.1-16.8) 12 p = 0.99
45-54y 122 14.1 (12.1-16.1) 12 p = 0.36
55-64y 50 14.3 (11.7-16.9) 12 p = 0.83
65+y 35 17.8 (13.8-21.8) 14 p = 0.03
Missing 11 10.55 12
Hinderaker et al. BMC Public Health 2011, 11:306
http://www.biomedcentral.com/1471-2458/11/306
Page 3 of 6
(95% CI 1.3 - 1.7) than patients not reporting weight
loss.
Discussion
Delay in care seeking is a major challenge for patients
with TB and is made worse for the poor [10], contribut-
ing to an ever increasing cycle of poverty. Consequently,
understanding and addressing this problem is crucial to
improving health and reducing poverty. Other studies
have highlighted the role of traditional healers in contri-
buting to delay in care seeking for TB in rural Tanzania
[11] and in other low-income countries [12-15]. Our
study has shown that 50% of the new smear positive
patients in selected districts of Tanzania suffer from
symptoms for 12 weeks or more before they are diag-
nosed with TB and treatment is initiated. The mean
delay was 15.2 weeks, showing a skewed frequency dis-
tribution. Our data covers around 10% of TB patients in
the FIDELIS projects in the country and the numbers
equal around 4% of annual new smear positive cases in
Tanzania [7]. Project reports from two of these projects
with over 6000 patients showed that 36% of the patients
indicated their treatment delay was 12 weeks or more.
In our study a higher proportion was delayed, so these
findings may not be representative for the whole coun-
try. Tanzania has more than 100 ethnic groups with dif-
ferent cultures, but the urbanization during the last
decades may have created a more uniform culture and
some loss of ties to extended family and ethnic group.
Health seeking behaviour is markedly influenced by
location and culture, as shown in the review mentioned
earlier [3].
Before receiving their diagnosis 40% of the partici-
pants had seen a private practitioner, and 20% of
respondents reported consulting a traditional healer,
with similar proportions for urban and rural dwellers. In
a study in Mwanza region the proportion if TB patients
visiting traditional healer was 38.9% in 1998 [5], and a
study from Pwani region in 2007 showed that 7.1% had
consulted traditional healer [4]. Half of our patients had
seen the traditional healer 5 weeks or less before the
time of their diagnosis. There is a potential for earlier
detection of TB in these patients if the traditional hea-
lers would refer all coughing patients to a diagnostic
clinic. However, this would require good communica-
tion with this sector, as has been demonstrated in other
settings such as Malawi [16]. The data regarding tradi-
tional healers may be biased utilizing the interview for-
mat, as patients may be reluctant to divulge this care-
seeking behaviour to professional health care providers.
We have no information of the magnitude of this poten-
tial information bias.
Patients in Handeni district had longer median delay
than Hai, and Mbozi had shorter delays. This is
Table 2 Symptom duration and treatment delay of TB
patients in the study
Symptom duration
(weeks)
Treatment delay
(weeks)
Symptom n Mean Median n Mean Median
All 1161 15.2 12
Missing 18
Cough
No 2 2
Yes 1174 13.5 12 1158 15.2 12
Missing 3 19
Hemoptysis
No 921 921
Yes 182 5.6 3 182 16.1 12
Missing 76 76
Fever
No 1
Yes 1053 10.0 8 1080 15.3 12
Missing 125
Weight loss
No 14
Yes 978 10.2 8 1025 15.7 12
Missing 187
Other complaints
Chest pain 661 14.5 12
Dyspnoea* 79 19.3 15
Weakness 237 15.3 12
Anorexia 57 15.9 12
Diarrhoea* 16 22.5 20
*Mann-Whitney test p < 0.05, comparing delay in cases who reported
symptom with those who did not.
Table 3 Health services consulted before diagnosis, and
corresponding treatment delay in FIDELIS projects in
Tanzania
Delay (weeks) Mann-
Whitney
n (%) Mean Median test
Visited traditional healer
before
924 100% p < 0.01
-yes 183 20% 18.6 15
-no 741 80% 14.9 12
Visited private clinic
before
962 100% p = 0.19
-yes 431 45% 14.7 12
-no 531 55% 16.3 12
Visited public facility
before
1024 100% p = 0.01
-yes 665 65% 16.4 12
-no 359 35% 13.8 12
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somewhat expected due to a greater scarcity in diagnos-
tic facilities as indicated by the number of new sputum
smear fixing sites in the FIDELIS project in addition to
the old ones; Mbozi got two extra sites and Handeni got
five extra sites based on a pre-project needs assessment.
Even though Mbozi district has 30% more people, the
project planned only two extra smear fixing sites. Urban
and rural dwellers of Mbeya had similar duration of
delay, and also similar utilization of traditional healer.
We note that the reported duration of cough is basi-
cally the same as the total duration of the treatment
delay, and underscores that cough is often the first and
most consistent symptom in pulmonary TB. Weight loss
was a very common symptom but its duration was
shorter than the total duration of delay, only 8 weeks.
This is expected because weight loss takes some time to
appear visibly in the body and would be expected a bit
later than the cough. In line with this, haemoptysis had
a duration of only three weeks, and may in these cases
have been the symptom that precipitated the patient to
seek help.
Patients with dyspnoea had a longer delay, which may
indicate that their disease was more advanced. Also,
patients who mentioned diarrhoea as a symptom had a
longer delay. We have no data to speculate on the
causes of this, e.g. HIV status. Weight loss was a clear
risk factor for a prolonged delay, and this makes sense
as weight loss takes some time to manifest itself. In our
skewed data the odds ratio of this variable cannot not
be taken as an approximation of risk (see later). How-
ever, linear regression with log-transformed delay
showed that patients reporting weight loss have around
one and a half week longer delay than patients not
reporting weight loss.
Our study has a number of potential weaknesses. It
was not population based, but facility-based covering all
government facilities in the selected districts, and a
selection of private clinics routinely reporting to NTLP.
However, in Tanzania the large majority of TB patients
are diagnosed at facilities reporting to the NTLP. Also,
our data was comprised of a selection of interview
forms that were managed and stored by the district TB
coordinator (DTLC). This could indicate a self-selection
of districts where the DTLC is more conscientious and
provide better services, even though there is no evidence
for this potential bias. Furthermore, information bias
may have arisen during the interviews depending on the
beliefs of the interviewer. We have no information on
this, and no quality assurance measures were done for
the interview, nor for quality of the forms. These biases
may give wrong estimates of delay, and we do not know
whether this is consistent in the various locations. There
were also some methodological weaknesses. In logistic
regression analysis the resulting odds ratio is
representative for the risk ratio if the outcome is fairly
rare. Hence, the exact odds ratios of common outcomes
should not be interpreted as valid quantification of
risks. Regression modelling is usually not advised for
skewed data, unless the dataset is large. We therefore
compared with log-transformed data on delay.
Conclusion
In our study half of the new smear positive pulmonary
patients reviewed had a delay of 12 weeks or more, and
visiting a traditional healer prolonged the delay. Rural
and urban patients reported similar delay. Patients aged
15-24 years and 65 years and older had longer delay
than patients aged 25-34 years. Delays in patients with
symptoms of dyspnoea and weight loss may simply indi-
cate longer duration of disease.
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